Study with study medication for acute alcohol-related hepatitis (Part A SRD)

Are you

• a healthy man or infertile woman
• between 18 and 65 years (inclusive)
• with a BMI between 18.5 and 30.0 kg/m² (inclusive) 
• a smoker, non-smoker, or ex-smoker
  • (smoking is not allowed during the stay in the unit)
• and does not use daily medication

What does this trial involve?

In study 2500291, SGS CPU is investigating study medication for acute alcohol-related hepatitis. 
During +/- 15 weeks you will have the following appointments:

• a screening visit
• an in-house stay of 5 days (4 nights)
• 8 morning ambulatory visits
• an end of trial visit

Take part in this trial and

• contribute to the medicine of tomorrow
• a compensation will be provided

This study was approved by the competent Belgian health authorities and an independent ethics committee.

EU Clinical Trial number: 2025-523262-25

View information leaflet Part A DG5a cohort 1

View study dates Part A DG5a cohort 1

View information leaflet Part A DG5a cohort 2

View study dates Part A DG5a cohort 2

View information leaflet Part A DG5b cohort 1

View study dates Part A DG5b cohort 1

View information leaflet Part A DG5b cohort 2

View study dates Part A DG5b cohort 2